Jon Coleman's most recent trade in Dexcom Inc was a trade of 4,912 Common Stock done at an average price of $73 . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DexCom | Jon Coleman | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 03 Jun 2026 | 4,912 | 100,361 (0%) | 0% | 73 | 358,576 | Common Stock |
| DexCom | Jon Coleman | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 74.13 per share. | 03 Jun 2026 | 4,911 | 95,450 (0%) | 0% | 74.1 | 364,052 | Common Stock |
| DexCom | Jon Coleman | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.90 per share. | 22 May 2026 | 7,362 | 105,273 (0%) | 0% | 71.9 | 529,328 | Common Stock |
| DexCom | Jon Coleman | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2026 | 43,897 | 112,635 (0%) | 0% | 0 | Common Stock |